Lion Point Capital’s Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant NFYS.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,225,000
Closed -$12.2M 38
2021
Q4
$12.2M Buy
+1,225,000
New +$12.1M 3.26% 12

Other funds holding NFYS.U

Lion Point Capital's NFYS.U Position: Q1 2022 in Review

Lion Point Capital sold out of Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (NFYS.U) in Q1 2022, closing a stake of 1,225,000 shares — an estimated $12.2M sold.

Lion Point Capital first reported a position in NFYS.U in Q4 2021 and held it in 1 quarter. The position peaked at $12.2M in Q4 2021. 23 funds tracked by Wall St. Rank hold NFYS.U as of Q1 2022.

  • Lion Point Capital reported no remaining Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position as of Q1 2022 after selling out during the quarter.
  • Lion Point Capital sold 1,225,000 Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant shares in Q1 2022, an estimated $12.2M.
  • Lion Point Capital first reported a position in Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant in Q4 2021 and held it in 1 quarter.
  • Lion Point Capital's Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position peaked at $12.2M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant as of Q1 2022.

Based on Lion Point Capital's 13F filing for Q1 2022, filed 16 May 2022.